Changes in cystic fibrosis airway microbiota at pulmonary exacerbation
Open accessAbstract
RATIONALE: In persons with cystic fibrosis (CF), repeated exacerbations of pulmonary symptoms are associated with a progressive decline in lung function. Changes in the airway microbiota around the time of exacerbations are not well understood. OBJECTIVES: To characterize changes in airway bacterial communities around the time of exacerbations and to identify predictors for these changes. METHODS: DNA prepared from 68 paired baseline and exacerbation sputum samples collected from 28 patients with CF were subjected to barcoded 16S rRNA gene pyrosequencing. Bacterial density was calculated by quantitative PCR. MEASUREMENTS AND MAIN RESULTS: Overall, significant differences in bacterial community diversity and bacterial density between baseline and exacerbation samples were not observed. However, considerable changes in community structures were observed in a subset of patients. In these patients, the dominant taxa and initial level of community diversity were significant predictors of the magnitude of community structure changes at exacerbation. Pseudomonas-dominant communities became more diverse at exacerbation compared with communities with other or no dominant species. The relative abundance of Gemella increased in 24 (83%) of 29 samples at exacerbation and was found to be the most discriminative genus between baseline and exacerbation samples. CONCLUSIONS: The magnitude of changes in the CF lung microbiota around the time of exacerbation was found to be largely dependent on community diversity and composition at baseline. Certain genera appear to play important roles in driving change in airway bacterial community composition at exacerbation. Gemella might play a direct role in and/or be a biomarker for pulmonary exacerbation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Culture-independent studies comparing bacterial communities at baseline and during exacerbations in the airways of patients with COPD, cystic fibrosis, or bronchiectasis consistently report no increase in bacterial burden and no decrease in community diversity during exacerbations.
“With remarkable consistency, all studies report no increase in bacterial burden and no decrease in community diversity during exacerbations.”
From The microbiome and critical illness (2016) · cites this paper as [136]
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 20,966 · see citing works
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828 · see citing works
An Ordination of the Upland Forest Communities of Southern Wisconsin
Bray, J. R., & Curtis, J. T. (1957) · Ecological Monographs · doi:10.2307/1942268 · Cited by 11,736 · see citing works
Reducing the Effects of PCR Amplification and Sequencing Artifacts on 16S rRNA-Based Studies
Schloss, P. D., Gevers, D., & Westcott, S. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027310 · Cited by 2,112 · see citing works
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,931 · see citing works
The keystone-pathogen hypothesis
Hajishengallis, G., Darveau, R. P., & Curtis, M. A. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2873 · Cited by 1,790 · see citing works
Hajishengallis, G., Liang, S., Payne, M. A., Hashim, A., Jotwani, R., Eskan, M. A., McIntosh, M. L., Alsam, A., Kirkwood, K. L., Lambris, J. D., et al. (2011) · Cell Host & Microbe · doi:10.1016/j.chom.2011.10.006 · Cited by 1,154 · see citing works
Nonparametric estimation of Shannon’s index of diversity when there are unseen species in sample
Chao, A., & Shen, T. (2003) · Environmental and Ecological Statistics · doi:10.1023/a:1026096204727 · Cited by 806 · see citing works
Predictive 5-year survivorship model of cystic fibrosis
Liou, T. G., Adler, F. R., FitzSimmons, S. C., Cahill, B. C., Hibbs, J. R., & Marshall, B. C. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.4.345 · Cited by 749 · see citing works
Decade-long bacterial community dynamics in cystic fibrosis airways
Zhao, J., Schloss, P. D., Kalikin, L. M., Carmody, L. A., Foster, B. K., Petrosino, J. F., Cavalcoli, J. D., VanDevanter, D. R., Murray, S., Li, J. Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120577109 · Cited by 599 · see citing works
Self-citationDetection of Anaerobic Bacteria in High Numbers in Sputum from Patients with Cystic Fibrosis
Tunney, M. M., Field, T. R., Moriarty, T. F., Patrick, S., Doering, G., Muhlebach, M. S., Wolfgang, M. C., Boucher, R. C., Gilpin, D. F., McDowell, A., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1151oc · Cited by 466 · see citing works
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445 · see citing works
Reproducibility and quantitation of amplicon sequencing-based detection
Zhou, J. Z., Wu, L., Deng, Y., Zhi, X., Jiang, Y., Tu, Q., Xie, J., Nostrand, J. D. V., He, Z., & Yang, Y. (2011) · The ISME Journal · doi:10.1038/ismej.2011.11 · Cited by 438 · see citing works
Harris, J. K., Groote, M. A. D., Sagel, S. D., Zemanick, E. T., Kapsner, R. K., Penvari, C., Kaess, H., Deterding, R. R., Accurso, F. J., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709804104 · Cited by 373 · see citing works
Fodor, A. A., Klem, E., Gilpin, D. F., Elborn, J. S., Boucher, R. C., Tunney, M. M., & Wolfgang, M. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045001 · Cited by 349 · see citing works
Impact of Recent Pulmonary Exacerbations on Quality of Life in Patients With Cystic Fibrosis
Britto, M. T., Kotagal, U. R., Hornung, R., Atherton, H. D., Tsevat, J., & Wilmott, R. W. (2002) · CHEST Journal · doi:10.1378/chest.121.1.64 · Cited by 347 · see citing works
Rogers, G. B., Carroll, M. P., Serisier, D. J., Hockey, P., Jones, G., & Bruce, K. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5176-5183.2004 · Cited by 318 · see citing works
Sibley, C. D., Parkins, M. D., Rabin, H. R., Duan, K., Nørgaard, J. C., & Surette, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804326105 · Cited by 313 · see citing works
Sanders, D. B., Bittner, R. C. L., Rosenfeld, M., Redding, G. J., & Goss, C. H. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21374 · Cited by 251 · see citing works
Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis
Guss, A. M., Roeselers, G., Newton, I. L. G., Young, C. R., Klepac‐Ceraj, V., Lory, S. J., & Cavanaugh, C. M. (2010) · The ISME Journal · doi:10.1038/ismej.2010.88 · Cited by 198 · see citing works
Tunney, M. M., Klem, E., Fodor, A. A., Gilpin, D. F., Moriarty, T. F., McGrath, S., Muhlebach, M. S., Boucher, R. C., Cardwell, C. R., Doering, G., et al. (2011) · Thorax · doi:10.1136/thx.2010.137281 · Cited by 176 · see citing works
Stressmann, F. A., Rogers, G. B., Gast, C., Marsh, P., Vermeer, L. S., Carroll, M. P., Hoffman, L. R., Daniels, T. W. V., Patel, N., Forbes, B., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-200932 · Cited by 153 · see citing works
Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann, F. A., Rogers, G. B., Marsh, P., Lilley, A. K., Daniels, T. W. V., Carroll, M. P., Hoffman, L. R., Jones, G., Allen, C. E., Patel, N., et al. (2011) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2011.05.002 · Cited by 130 · see citing works
Nick, J. A., Chacon, C. S., Brayshaw, S. J., Jones, M. C., Barboa, C., Clair, C. G. S., Young, R. L., Nichols, D. P., Janssen, J. S., Huitt, G. A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0092oc · Cited by 123 · see citing works
The Cost of Medical Care for Patients With Cystic Fibrosis in a Health Maintenance Organization
Lieu, T. A., Ray, G. T., Farmer, G., & Shay, G. F. (1999) · PEDIATRICS · doi:10.1542/peds.103.6.e72 · Cited by 122 · see citing works
One-year Outcome after Severe Pulmonary Exacerbation in Adults with Cystic Fibrosis
Ellaffi, M., Vinsonneau, C., Coste, J., Hubert, D., Burgel, P., Dhainaut, J.-F., & Dusser, D. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-667oc · Cited by 115 · see citing works
Reducing bias in bacterial community analysis of lower respiratory infections
Rogers, G. B., Cuthbertson, L., Hoffman, L. R., Wing, P. A. C., Pope, C. E., Hooftman, D. A. P., Lilley, A. K., Oliver, A., Carroll, M. P., Bruce, K. D., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.145 · Cited by 107 · see citing works
Robson, M., Abbott, J., Webb, K., Dodd, M. E., & Walsworth-Bell, J. (1992) · Thorax · doi:10.1136/thx.47.9.684 · Cited by 93 · see citing works
Rogers, G. B., Marsh, P., Stressmann, F. A., Allen, C. E., Daniels, T. V., Carroll, M. P., & Bruce, K. D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03189.x · Cited by 88 · see citing works
Zemanick, E. T., Wagner, B. D., Sagel, S. D., Stevens, M. J., Accurso, F. J., & Harris, J. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015101 · Cited by 87 · see citing works
The genus Prevotella in cystic fibrosis airways
Field, T. R., Sibley, C. D., Parkins, M. D., Rabin, H. R., & Surette, M. G. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.04.002 · Cited by 79 · see citing works
Assessing the diagnostic importance of nonviable bacterial cells in respiratory infections
Rogers, G. B., Stressmann, F. A., Koller, G., Daniels, T. W. V., Carroll, M. P., & Bruce, K. D. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2008.06.011 · Cited by 79 · see citing works
Zhao, J., Carmody, L. A., Kalikin, L. M., Li, J. Z., Petrosino, J. F., Schloss, P. D., Young, V. B., & LiPuma, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033127 · Cited by 69 · see citing works
Impact of antibiotic treatment for pulmonary exacerbations on bacterial diversity in cystic fibrosis
Daniels, T. W. V., Rogers, G. B., Stressmann, F. A., Gast, C., Bruce, K. D., Jones, G. R., Connett, G. J., Legg, J. P., & Carroll, M. P. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.05.008 · Cited by 61 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Microbiome and the Respiratory Tract
Dickson, R. P., Erb-Downward, J. R., Martinez, F. J., & Huffnagle, G. B. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105238 · Cited by 953 · see citing works
The dynamic lung microbiome in health and disease
Natalini, J. G., Singh, S., & Segal, L. N. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00821-x · Cited by 528 · see citing works
The role of the microbiome in exacerbations of chronic lung diseases
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61136-3 · Cited by 495 · see citing works
The microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460 · see citing works
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 466 · see citing works
Lung microbiota across age and disease stage in cystic fibrosis
Coburn, B. A., Wang, P. W., Caballero, J. D., Clark, S. T., Brahma, V., Donaldson, S. L., Zhang, Y., Surendra, A., Gong, Y., Tullis, D. E., et al. (2015) · Scientific Reports · doi:10.1038/srep10241 · Cited by 388 · see citing works
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
O’Dwyer, D. N., Dickson, R. P., & Moore, B. B. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600279 · Cited by 362 · see citing works
The lung mycobiome: an emerging field of the human respiratory microbiome
Nguyen, L. D. N., Viscogliosi, E., & Delhaes, L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00089 · Cited by 260 · see citing works
Interplay between the lung microbiome and lung cancer
Mao, Q., Jiang, F., Yin, R. H., Wang, J., Xia, W., Dong, G., Ma, W., Yang, Y., Xu, L., & Hu, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.036 · Cited by 251 · see citing works
Liu, H., Tao, L., Zhang, J., Zhu, Y., Zheng, Y., Liu, D., Zhou, M., Ke, H., Shi, M., & Qu, J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31098 · Cited by 235 · see citing works
Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease
Flynn, J. M., Niccum, D. E., Dunitz, J., & Hunter, R. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005846 · Cited by 238 · see citing works
Airway microbiota across age and disease spectrum in cystic fibrosis
Zemanick, E. T., Wagner, B. D., Robertson, C. E., Ahrens, R. C., Chmiel, J. F., Clancy, J. P., Gibson, R. L., Harris, W. T., Kurland, G., Laguna, T. A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00832-2017 · Cited by 229 · see citing works
Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology
Chen, Y., Ji, F., Guo, J., Shi, D., Fang, D., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep34055 · Cited by 205 · see citing works
Cystic Fibrosis Lung Infections: Polymicrobial, Complex, and Hard to Treat
Filkins, L., & O’Toole, G. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005258 · Cited by 202 · see citing works
Directing traffic: IL ‐17 and IL ‐22 coordinate pulmonary immune defense
McAleer, J. P., & Kolls, J. K. (2014) · Immunological Reviews · doi:10.1111/imr.12183 · Cited by 195 · see citing works
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
Parkins, M. D., & Floto, R. A. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.03.012 · Cited by 190 · see citing works
Chmiel, J. F., Aksamit, T. R., Chotirmall, S. H., Dasenbrook, E. C., Elborn, J. S., LiPuma, J. J., Ranganathan, S., Waters, V. J., & Ratjen, F. A. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201402-050as · Cited by 191 · see citing works
The Microbiome in Cystic Fibrosis
Huang, Y. J., & LiPuma, J. J. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.10.003 · Cited by 165 · see citing works
Specimen Collection, Transport, and Processing: Bacteriology
Baron, E. J. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch18 · Cited by 158 · see citing works
Lung Microbiome for Clinicians. New Discoveries about Bugs in Healthy and Diseased Lungs
Segal, L. N., Rom, W. N., & Weiden, M. D. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201310-339fr · Cited by 151 · see citing works
Multicenter comparison of lung and oral microbiomes of HIV-infected and HIV-uninfected individuals.
Beck, J. M., Schloss, P. D., Venkataraman, A., Twigg, H., Jablonski, K. A., Bushman, F. D., Campbell, T. B., Charlson, E. S., Collman, R. G., Crothers, K., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0128oc · Cited by 150 · see citing works
Self-citationCarmody, L. A., Zhao, J., Kalikin, L. M., LeBar, W., Simon, R. H., Venkataraman, A., Schmidt, T. M., Abdo, Z., Schloss, P. D., & LiPuma, J. J. (2015) · Microbiome · doi:10.1186/s40168-015-0074-9 · Cited by 135 · see citing works
Self-citationCaballero, J. D., Clark, S. T., Coburn, B. A., Zhang, Y., Wang, P. W., Donaldson, S. L., Tullis, D. E., Yau, Y. C. W., Waters, V. J., Hwang, D. M., et al. (2015) · mBio · doi:10.1128/mbio.00981-15 · Cited by 132 · see citing works
Cox, M. J., Turek, E. M., Hennessy, C., Mirza, G. K., James, P. L., Coleman, M., Jones, A., Wilson, R., Bilton, D., Cookson, W., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170622 · Cited by 130 · see citing works
Feigelman, R., Kahlert, C. R., Baty, F., Rassouli, F., Kleiner, R. L., Kohler, P. P., Brutsche, M. H., & von Mering, C. (2017) · Microbiome · doi:10.1186/s40168-017-0234-1 · Cited by 126 · see citing works
Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract
Kiedrowski, M. R., & Bomberger, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03067 · Cited by 127 · see citing works
Whiteson, K., Bailey, B., Bergkessel, M., Conrad, D., Delhaès, L., Felts, B., Harris, J. K., Hunter, R. C., Lim, Y. W., Maughan, H., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2129pp · Cited by 122 · see citing works
Cuthbertson, L., Rogers, G. B., Walker, A. W., Oliver, A., Green, L. E., Daniels, T. W. V., Carroll, M. P., Parkhill, J., Bruce, K. D., & Gast, C. (2015) · The ISME Journal · doi:10.1038/ismej.2015.198 · Cited by 114 · see citing works
A Brave New World: The Lung Microbiota in an Era of Change
Segal, L. N., & Blaser, M. J. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201306-189mg · Cited by 114 · see citing works
Sanders, D. B., & Fink, A. K. (2016) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2016.04.001 · Cited by 109 · see citing works
Soret, P., Vandenborght, L., Francis-Oliviero, F., Coron, N., Enaud, R., Avalos, M., Schaeverbeke, T., Berger, P., Fayon, M. J., Thiébaut, R., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60015-4 · Cited by 103 · see citing works
Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
Acosta, N., Heirali, A., Somayaji, R., Surette, M. G., Workentine, M. L., Sibley, C. D., Rabin, H. R., & Parkins, M. D. (2018) · Thorax · doi:10.1136/thoraxjnl-2018-211510 · Cited by 93 · see citing works
Cystic fibrosis microbiology: Advances in antimicrobial therapy
Waters, V. J., & Smyth, A. R. (2015) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2015.02.005 · Cited by 95 · see citing works
Carmody, L. A., Caverly, L. J., Foster, B. K., Rogers, M. A. M., Kalikin, L. M., Simon, R. H., VanDevanter, D. R., & LiPuma, J. J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194060 · Cited by 90 · see citing works
The Lung Microbiome and Its Role in Pneumonia
Wu, B. G., & Segal, L. N. (2018) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2018.07.003 · Cited by 90 · see citing works
Ren, L., Zhang, R., Rao, J. Y., Xiao, Y., Zhang, Z., Yang, B., Cao, D., Zhong, H., Ning, P., Shang, Y., et al. (2018) · mSystems · doi:10.1128/msystems.00199-18 · Cited by 90 · see citing works
Healy, C. M., Muñoz‐Wolf, N., Strydom, J., Faherty, L., Williams, N. C., Kenny, S., Donnelly, S. C., & Cloonan, S. M. (2021) · Respiratory Research · doi:10.1186/s12931-021-01722-y · Cited by 89 · see citing works
Culture-based diagnostic microbiology in cystic fibrosis: Can we simplify the complexity?
Burns, J. L., & Rolain, J. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.09.004 · Cited by 87 · see citing works
Ecological networking of cystic fibrosis lung infections
Quinn, R. A., Whiteson, K., Lim, Y. W., Zhao, J., Conrad, D. J., LiPuma, J. J., Rohwer, F. L., & Stefanie Widder, A. (2016) · npj Biofilms and Microbiomes · doi:10.1038/s41522-016-0002-1 · Cited by 85 · see citing works
Defining antimicrobial resistance in cystic fibrosis
Kidd, T. J., Cantón, R., Ekkelenkamp, M. B., Johansen, H. K., Gilligan, P. H., LiPuma, J. J., Bell, S. C., Elborn, J. S., Flume, P. A., VanDevanter, D. R., et al. (2018) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2018.08.014 · Cited by 86 · see citing works
Sanders, D. B., Solomon, G. M., Beckett, V. V., West, N. E., Daines, C. L., Heltshe, S. L., VanDevanter, D. R., Spahr, J. E., Gibson, R. L., Nick, J. A., et al. (2017) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2017.04.005 · Cited by 87 · see citing works
Quinn, R. A., Whiteson, K., Lim, Y.-W., Salamon, P., Bailey, B., Mienardi, S., Sanchez, S. E., Blake, D. R., Conrad, D., & Rohwer, F. L. (2014) · The ISME Journal · doi:10.1038/ismej.2014.234 · Cited by 84 · see citing works
The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
Perdijk, O., Azzoni, R., & Marsland, B. J. (2023) · Physiological Reviews · doi:10.1152/physrev.00020.2023 · Cited by 88 · see citing works
Pulmonary Exacerbations in Children with Cystic Fibrosis
Waters, V. J., & Ratjen, F. A. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201502-098aw · Cited by 84 · see citing works
Cystic fibrosis lung microbiome: Opportunities to reconsider management of airway infection
Caverly, L. J., Zhao, J., & LiPuma, J. J. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23243 · Cited by 76 · see citing works
Raghuvanshi, R., Vasco, K. A., Vázquez‐Baeza, Y., Jiang, L., Morton, J. T., Li, D., González, A., Goldasich, L. D., Humphrey, G., Ackermann, G. L., et al. (2020) · mSystems · doi:10.1128/msystems.00292-20 · Cited by 73 · see citing works
Layeghifard, M., Li, H., Wang, P. W., Donaldson, S. L., Coburn, B. A., Clark, S. T., Caballero, J. D., Zhang, Y., Tullis, D. E., Yau, Y. C. W., et al. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0077-y · Cited by 78 · see citing works
Paganin, P., Fiscarelli, E. V., Assanti, V. T. G., Manuela, C., Bacci, G., Morelli, P., Dolce, D., Dalmastri, C., Alessandri, A. D., Lucidi, V., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124348 · Cited by 77 · see citing works
A longitudinal characterization of the Non-Cystic Fibrosis Bronchiectasis airway microbiome
Woo, T. E., Lim, R., Heirali, A., Acosta, N., Rabin, H. R., Mody, C. H., Somayaji, R., Surette, M. G., Sibley, C. D., Storey, D. G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42862-y · Cited by 75 · see citing works
Longitudinal sampling of the lung microbiota in individuals with cystic fibrosis
Whelan, F., Heirali, A., Rossi, L., Rabin, H. R., Parkins, M. D., & Surette, M. G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172811 · Cited by 71 · see citing works
Jorth, P. A., Ehsan, Z., Rezayat, A., Caldwell, E., Pope, C. E., Brewington, J. J., Goss, C. H., Benscoter, D. T., Clancy, J. P., & Singh, P. K. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.086 · Cited by 72 · see citing works
Selective pressures during chronic infection drive microbial competition and cooperation
Baishya, J., & Wakeman, C. A. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0089-2 · Cited by 70 · see citing works
Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms
Xu, N., Wang, L., Li, C., Ding, C., Li, C., Fan, W., Chen, C., & Gu, B. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr-20-156 · Cited by 71 · see citing works
Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New
O’Toole, G. A. (2017) · Journal of Bacteriology · doi:10.1128/jb.00561-17 · Cited by 62 · see citing works
Avalos, M., Alin, T., Métayer, C., Thiébaut, R., Enaud, R., & Delhaès, L. (2022) · Respiratory Research · doi:10.1186/s12931-022-02132-4 · Cited by 65 · see citing works
Mahboubi, M. A., Carmody, L. A., Foster, B. K., Kalikin, L. M., VanDevanter, D. R., & LiPuma, J. J. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02299-15 · Cited by 62 · see citing works
The composition of lung microbiome in lung cancer: a systematic review and meta-analysis
Najafi, S., Abedini, F., Jamalkandi, S. A., Shariati, P., Ahmadi, A., & Fesharaki, M. G. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02375-z · Cited by 61 · see citing works
Past, Present, and Future Research on the Lung Microbiome in Inflammatory Airway Disease
Caverly, L. J., Huang, Y. J., & Sze, M. A. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.05.011 · Cited by 61 · see citing works
The effects of inhaled aztreonam on the cystic fibrosis lung microbiome
Heirali, A., Workentine, M. L., Acosta, N., Poonja, A., Storey, D. G., Somayaji, R., Rabin, H. R., Whelan, F., Surette, M. G., & Parkins, M. D. (2017) · Microbiome · doi:10.1186/s40168-017-0265-7 · Cited by 60 · see citing works
The Microbiota, Chemical Symbiosis, and Human Disease
Redinbo, M. R. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.011 · Cited by 57 · see citing works
Reece, E., Bettio, P. H. D. A., & Renwick, J. (2021) · Antibiotics · doi:10.3390/antibiotics10070827 · Cited by 51 · see citing works
Hahn, A., Sanyal, A., Pérez, G. F., Colberg‐Poley, A. M., Campos, J. M., Rose, M. C., & Pérez‐Losada, M. (2016) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2016.09.002 · Cited by 55 · see citing works
The bacterial microbiota in inflammatory lung diseases
Huffnagle, G. B., & Dickson, R. P. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.05.022 · Cited by 53 · see citing works
Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration
Bevivino, A., Bacci, G., Dřevı́nek, P., Nelson, M. T., Hoffman, L. R., & Mengoni, A. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.07.008 · Cited by 55 · see citing works
Metabolomics of pulmonary exacerbations reveals the personalized nature of cystic fibrosis disease
Quinn, R. A., Lim, Y. W., Mak, T. D., Whiteson, K., Furlan, M., Conrad, D. J., Rohwer, F. L., & Dorrestein, P. C. (2016) · PeerJ · doi:10.7717/peerj.2174 · Cited by 51 · see citing works
Maintenance tobramycin primarily affects untargeted bacteria in the CF sputum microbiome
Nelson, M. T., Wolter, D. J., Eng, A., Weiss, E. J., Vo, A. T., Brittnacher, M., Hayden, H. S., Ravishankar, S., Bautista, G. E., Ratjen, A., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214187 · Cited by 51 · see citing works
Perault, A. I., Chandler, C. E., Rasko, D. A., Ernst, R. K., Wolfgang, M. C., & Cotter, P. A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.019 · Cited by 47 · see citing works
Abbas‐Egbariya, H., Haberman, Y., Braun, T., Hadar, R., Denson, L. A., Gal‐Mor, O., & Amir, A. (2022) · Genome biology · doi:10.1186/s13059-022-02637-7 · Cited by 48 · see citing works
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future
Thornton, C. S., & Parkins, M. D. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0042-1758732 · Cited by 49 · see citing works
Microbiota Present in Cystic Fibrosis Lungs as Revealed by Whole Genome Sequencing
Hauser, P. M., Bernard, T., Greub, G., Jaton, K., Pagni, M., & Hafen, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090934 · Cited by 46 · see citing works
Valentini, T., Lucas, S. K., Binder, K. A., Cameron, L. C., Motl, J. A., Dunitz, J., & Hunter, R. C. (2020) · Nature Communications · doi:10.1038/s41467-020-16163-2 · Cited by 48 · see citing works
Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice
Caverly, L. J., & LiPuma, J. J. (2018) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2018.1513331 · Cited by 44 · see citing works
Lee, S. Y., Aogáin, M. M., Fam, K. D., Chia, K. L., Ali, N. A. B. M., Yap, M. M. C., Yap, P. H., Chotirmall, S. H., & Lim, C. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225636 · Cited by 45 · see citing works
Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease
Cribbs, S. K., & Beck, J. M. (2016) · Translational research · doi:10.1016/j.trsl.2016.07.022 · Cited by 44 · see citing works
Bacci, G., Mengoni, A., Fiscarelli, E. V., Segata, N., Taccetti, G., Dolce, D., Paganin, P., Morelli, P., Assanti, V. T. G., Alessandri, A. D., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081654 · Cited by 44 · see citing works
Chellappan, D. K., Ning, Q. L. S., Min, S. K. S., Bin, S. Y., Pang, J.-C., Shi, T. P., Mei, S. W. E., Yee, T. H., Qi, O. J., Thangavelu, L. P., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108732 · Cited by 44 · see citing works
Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways
Khanolkar, R. A., Clark, S. T., Wang, P. W., Hwang, D. M., Yau, Y. C. W., Waters, V. J., & Guttman, D. S. (2020) · mSystems · doi:10.1128/msystems.00809-20 · Cited by 43 · see citing works
Decreased efficacy of antimicrobial agents in a polymicrobial environment
O’Brien, T. J., Figueroa, W., & Welch, M. (2022) · The ISME Journal · doi:10.1038/s41396-022-01218-7 · Cited by 42 · see citing works
The airway microbiota in early cystic fibrosis lung disease
Frayman, K. B., Armstrong, D., Grimwood, K., & Ranganathan, S. (2017) · Pediatric Pulmonology · doi:10.1002/ppul.23782 · Cited by 42 · see citing works
Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment
Li, J., Zheng, H., & Leung, S. S. Y. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03379-8 · Cited by 41 · see citing works
The Human Respiratory Microbiome: Implications and Impact
Mitchell, A. B., & Glanville, A. R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1617441 · Cited by 37 · see citing works
Caverly, L. J., Carmody, L. A., Haig, S., Kotlarz, N., Kalikin, L. M., Raskin, L. M., & LiPuma, J. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153876 · Cited by 37 · see citing works
Bacci, G., Paganin, P., Lopez, L., Vanni, C., Dalmastri, C., Cantale, C., Daddiego, L., Perrotta, G., Dolce, D., Morelli, P., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156807 · Cited by 36 · see citing works
Update in Cystic Fibrosis 2014
Ong, T., & Ramsey, B. W. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0656up · Cited by 36 · see citing works
Palmer, G. C., & Whiteley, M. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0003-2014 · Cited by 36 · see citing works
Stefanie Widder, A., Zhao, J., Carmody, L. A., Zhang, Q., Kalikin, L. M., Schloss, P. D., & LiPuma, J. J. (2021) · The ISME Journal · doi:10.1038/s41396-021-01129-z · Cited by 36 · see citing works
Exploring the Cystic Fibrosis Lung Microbiome: Making the Most of a Sticky Situation
Thornton, C. S., Acosta, N., Surette, M. G., & Parkins, M. D. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piac036 · Cited by 34 · see citing works
Lu, J., Carmody, L. A., Opron, K., Simon, R. H., Kalikin, L. M., Caverly, L. J., & LiPuma, J. J. (2020) · mSystems · doi:10.1128/msystems.00296-20 · Cited by 36 · see citing works
Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability
Caverly, L. J., Lu, J., Carmody, L. A., Kalikin, L. M., Shedden, K., Opron, K., Azar, M., Cahalan, S. E., Foster, B. K., VanDevanter, D. R., et al. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201903-270oc · Cited by 34 · see citing works
Chin, M., Zoysa, M. D., Slinger, R., Gaudet, E., Vandemheen, K. L., Chan, F., Hyde, L., Mah, T., Ferris, W., Mallick, R., et al. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2014.11.009 · Cited by 34 · see citing works
Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy
Lopes, S. P., Azevedo, N. F., & Pereira, M. O. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.847898 · Cited by 31 · see citing works
Heirali, A., McKeon, S., Purighalla, S., Storey, D. G., Rossi, L., Costilhes, G., Drews, S. J., Rabin, H. R., Surette, M. G., & Parkins, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148534 · Cited by 33 · see citing works
Keravec, M., Mounier, J., Prestat, E., Vallet, S., Jansson, J. K., Burgaud, G., Rosec, S., Gouriou, S., Rault, G., Coton, E., et al. (2015) · SpringerPlus · doi:10.1186/s40064-015-1207-0 · Cited by 32 · see citing works
The pediatric microbiome and the lung
Tracy, M. C., Cogen, J. D., & Hoffman, L. R. (2015) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000212 · Cited by 32 · see citing works
Radiographic Honeycombing and Altered Lung Microbiota in Patients with Idiopathic Pulmonary Fibrosis
Dickson, R. P., Huffnagle, G. B., Flaherty, K. R., White, E. S., Martínez, F. J., Erb‐Downward, J. R., Moore, B. B., & O’Dwyer, D. N. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0680le · Cited by 30 · see citing works
Bacci, G., Taccetti, G., Dolce, D., Armanini, F., Segata, N., Cesare, F. D., Lucidi, V., Fiscarelli, E. V., Morelli, P., Casciaro, R., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8071003 · Cited by 29 · see citing works
Microbial diversity within the airway microbiome in chronic pediatric lung diseases
Hahn, A., Warnken, S., Pérez‐Losada, M., Freishtat, R. J., & Crandall, K. A. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.12.006 · Cited by 29 · see citing works
Hahn, A., Whiteson, K., Davis, T. J., Phan, J. L., Sami, I. R., Koumbourlis, A. C., Freishtat, R. J., Crandall, K. A., & Bean, H. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00174 · Cited by 28 · see citing works
The effects of cycled inhaled aztreonam on the cystic fibrosis (CF) lung microbiome
Heirali, A., Acosta, N., Storey, D. G., Workentine, M. L., Somayaji, R., Laforest‐Lapointe, I., Leung, W. M., Quon, B. S., Berthiaume, Y., Rabin, H. R., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.02.010 · Cited by 27 · see citing works
Longitudinal development of the airway microbiota in infants with cystic fibrosis
Ahmed, B., Cox, M. J., Cuthbertson, L., James, P. L., Cookson, W., Davies, J. C., Moffatt, M. F., & Bush, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-41597-0 · Cited by 27 · see citing works
- Authors
- Carmody, L. A., Zhao, J., Schloss, P. D., Petrosino, J. F., Murray, S., Young, V. B., Li, J. Z., & LiPuma, J. J.
- Affiliations
- University of Michigan (US)
- Microbiology and Immunology
- Baylor College of Medicine (US)
- Departments of Pediatrics and Communicable Disease and
- Corresponding author
- LiPuma, John J.
- ORCID
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-06-01
- Volume
- 10
- Issue
- 3
- Pages
- 179-187
- ISSN
- 2325-6621 (ISSN-L)
- 2329-6933
- PMC
- PMC3960905
- OpenAlex
- W2129800212
- Cited by
- 239
- References
- 34
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 12 · 2023: 19 · 2022: 19 · 2021: 19 · 2020: 23 · 2019: 22 · 2018: 18 · 2017: 28 · 2016: 17 · 2015: 30 · 2014: 15 · 2013: 3
- FWCI
- 17.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the American Thoracic Society (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cystic Fibrosis Foundation
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health (5rc1hl100809-02)
- National Heart, Lung, and Blood Institute (U01HL098961, RC1-HL100809, 1RC1HL100809-01)
- National Human Genome Research Institute (R01HG005975, R01HG004906)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933)
- National Center for Research Resources (UL1RR024986)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- cystic fibrosis, pulmonary exacerbations, airway microbiome, bacterial community diversity, community composition, Pseudomonas, Gemella, biomarkers, lung function decline
- MeSH terms
- Adolescent, Adult, Child, Cystic Fibrosis, Female, Humans, Lung, Male, Middle Aged, Sputum, Disease Progression, Young Adult, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review